These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 8190113

  • 1. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA, Miller RC, Eck M, Paquet JL.
    Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
    [Abstract] [Full Text] [Related]

  • 2. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
    Matsui H, Lazareno S, Birdsall NJ.
    Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
    [Abstract] [Full Text] [Related]

  • 3. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A, Tucek S.
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [Abstract] [Full Text] [Related]

  • 4. Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor.
    Lee NH, Hu J, el-Fakahany EE.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):312-6. PubMed ID: 1625205
    [Abstract] [Full Text] [Related]

  • 5. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 6. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

  • 7. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991
    [Abstract] [Full Text] [Related]

  • 8. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A, Christopoulos A, Mitchelson F.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
    May LT, Avlani VA, Langmead CJ, Herdon HJ, Wood MD, Sexton PM, Christopoulos A.
    Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors.
    Krajewski JL, Dickerson IM, Potter LT.
    Mol Pharmacol; 2001 Oct; 60(4):725-31. PubMed ID: 11562434
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
    Tränkle C, Kostenis E, Mohr K.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):172-8. PubMed ID: 11534857
    [Abstract] [Full Text] [Related]

  • 17. Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor.
    Ehlert FJ, Griffin MT.
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1039-60. PubMed ID: 18305010
    [Abstract] [Full Text] [Related]

  • 18. Asparagine, valine, and threonine in the third extracellular loop of muscarinic receptor have essential roles in the positive cooperativity of strychnine-like allosteric modulators.
    Jakubík J, Krejcí A, Dolezal V.
    J Pharmacol Exp Ther; 2005 May; 313(2):688-96. PubMed ID: 15647330
    [Abstract] [Full Text] [Related]

  • 19. Mutational disruption of a conserved disulfide bond in muscarinic acetylcholine receptors attenuates positive homotropic cooperativity between multiple allosteric sites and has subtype-dependent effects on the affinities of muscarinic allosteric ligands.
    Huang XP, Ellis J.
    Mol Pharmacol; 2007 Mar; 71(3):759-68. PubMed ID: 17132687
    [Abstract] [Full Text] [Related]

  • 20. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
    Potter LT, Ferrendelli CA, Hanchett HE, Hollifield MA, Lorenzi MV.
    Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.